Mankind Pharma Share Price Today | Stock Price & Mankind Pharma Share Screener

Track the current stock price of Mankind Pharma with an interactive chart. Analyse MANKIND share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Mankind Pharma stock quote in one place.

The quote of ₹2,285.50 sits between the 52-week low of ₹1,927.40 and the 52-week high of ₹2,617.90, and the latest session moved 1.43% from the previous close.

Screen Mankind Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MANKIND shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with RAMESH CHAND JUNEJA listed as chairperson or CEO, and it trades under ISIN INE634S01028.

Mankind Pharma Limited is an Indian pharmaceutical company incorporated in 1991. It develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products. The company operates in various therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. Mankind Pharma entered the consumer healthcare segment in 2007 and has since...more

Classification

Identifiers and Leadership

Screen MANKIND balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹28,080, up from ₹27,760 in 2025.

Latest statistics put total assets at ₹28,080 and shareholder funds at ₹16,561, with a leverage ratio of 0.48.

Screen Mankind Pharma income statement and profit fundamentals. Analyze MANKIND quarterly results. Mankind Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹4,080 and net profit was ₹574, equal to earnings per unit of ₹13.76, at an operating margin of 26%.

In that period expenses were ₹2,974, interest cost ₹110 and tax ₹195. The next period listed, 2026-Mar, shows revenue of ₹3,560 and net profit of ₹559.

Screen MANKIND cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹3,121, and net cash flow was an outflow of ₹12.

Over the same period, investing activities used ₹181 and financing activities used ₹2,953.

See Mankind Pharma shareholding pattern with promoter, FII, and DII holdings. Check Mankind Pharma promoter holding and ownership changes for MANKIND on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 72.62%, foreign institutions 9.37%, domestic institutions 15.56% and the public 1.26%, spread across 163,770 shareholders.

The shareholder count was 163,770 in 2026-Sept, compared with 166,715 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Mankind Pharma. Mankind Pharma dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹1.00 per unit for 2026-March, a yield of 0.04%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹1.00, ₹0.00 and ₹0.00 per unit.

See which indices include Mankind Pharma stock. Check MANKIND index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 24 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE 200 EQUAL WEIGHT, BSE INDEX BSE HC, BSE INDEX BSE200.

Get Mankind Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Mankind Pharma stock events that may affect MANKIND share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 26, 2026, with a record date of October 26, 2026.

It is followed by Annual General Meeting dated August 4, 2026 and Quarterly Result Announcement dated July 30, 2026.

Screen MANKIND competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen MANKIND latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 19, 2026.

The next most recent announcements are dated October 18, 2026 and October 18, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 23, 2026. This page covers 6 balance sheet periods, 15 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.